Abbott Laboratories
Abbott Laboratories is a broad-based global healthcare company headquartered in Abbott Park, Illinois, dedicated to improving life through scientific innovation. The corporation operates across four primary business segments: innovative medical devices, advanced diagnostic systems, nutritional products, and established branded generic pharmaceuticals. Its comprehensive portfolio includes world-leading cardiovascular devices, continuous glucose monitoring systems, point-of-care diagnostics, and specialized nutritional formulas for all ages. Abbott focuses heavily on developing technologies that facilitate early disease detection, continuous digital health monitoring, and targeted therapeutic interventions worldwide. To support an rapidly aging global population, the enterprise continually advances targeted medical therapies and adult clinical nutrition products that help manage chronic health conditions. The organization invests billions in continuous scientific research, digital health software, and clinical trials to enhance diagnostic accuracy and treatment efficiency. Operating across more than 160 countries, Abbott remains committed to delivering accessible healthcare innovations that improve human vitality and long-term wellbeing.
76 of the funds FundTelligence covers report a position in Abbott Laboratories.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 76
- Exposure themes
- Diabetes Technology, Glucose Monitoring, Obesity & Metabolic Health
Funds holding Abbott Laboratories
- Polar Capital Global Healthcare Select Fund — Polar Capital · 4.4 % (largest positions only, October 2026)
- SKAGEN Global — Storebrand · 4.29 % (full portfolio disclosed, October 2026)
- Schroder ISF Hlthcr Innovt — Schroders · 3.81 % (largest positions only, September 2026)
- Carnegie Global Quality Companies — Carnegie · 3.26 % (full portfolio disclosed, June 2026)
- JPM Global Healthcare Fund — JPM · 2.73 % (full portfolio disclosed, June 2026)
- Franklin Mutual U.S. Value Fund — Franklin Templeton · 2.45 % (full portfolio disclosed, September 2026)
- Vontobel US Equity — Vontobel · 2.09 % (full portfolio disclosed, February 2026)
- Franklin Mutual Global Discovery Fund — Franklin Templeton · 2.05 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 76 funds holding it.